Clinical Trial Update: Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia [Phase 2]

View source ↗

Summary

A Phase 2 trial investigated celecoxib for treating cervical intraepithelial neoplasia (CIN 2/3) with completed results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Intraepithelial Neoplasia 3

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Cervical Carcinoma, Cervical Intraepithelial Neoplasia Grade 2/3 | Phase 2 | Status: COMPLETED | Results posted: 2017-09-15